b
r
c
novel
tetrahydrocarbazol
inhibit
replic
varieti
unrel
virus
vitro
ec
valu
nm
replic
adenoviru
polyoma
viru
episom
mainten
human
papillomavirus
hpv
epsteinbarr
viru
ebv
suscept
compound
inhibit
virus
herp
simplex
viru
human
immunodefici
viru
hiv
lytic
replic
ebv
suscept
concentr
inhibit
growth
cell
line
immort
ebv
hpv
ec
valu
rang
nm
depend
cell
line
compound
induc
either
apoptosi
cytostasi
concentr
nm
also
inhibit
cell
line
immort
nonvir
mechan
littl
effect
primari
cell
cc
valu
keratinocyt
fibroblast
lymphocyt
endotheli
bone
marrow
progenitor
cell
pattern
inhibit
includ
divers
virus
well
growth
immort
cell
vari
origin
suggest
target
host
cell
protein
rather
viral
protein
preliminari
mechan
studi
indic
act
induc
subset
interferonstimul
gene
tremend
progress
made
treat
viral
infect
recent
decad
success
stori
includ
acyclovir
prodrug
herp
simplex
viru
hsv
two
neuraminidas
inhibitor
influenza
five
antivir
drug
hepat
b
hbv
almost
twodozen
human
immunodefici
viru
hiv
drug
despit
signific
advanc
howev
mani
common
viral
infect
still
safe
effect
treatment
exampl
antivir
drug
either
dengu
viru
caus
million
case
dengu
fever
year
moren
fauci
oncogen
human
papillomavirus
caus
cervic
cancer
preval
us
women
dunn
et
al
success
stori
discoveri
develop
new
antivir
drug
achiev
focus
viral
target
drawback
approach
unless
virus
close
relat
separ
drug
discoveri
develop
effort
requir
viru
case
multipl
inhibitor
need
combin
combat
rapid
develop
resist
clearli
case
hiv
expect
case
hepat
c
hcv
grunberg
et
al
inhibit
pathogen
target
still
great
valu
clearli
continu
yield
benefici
new
drug
use
host
target
antivir
therapi
grow
exampl
one
newest
class
hiv
inhibitor
antagonist
target
cell
surfac
receptor
block
entri
viru
schlect
et
al
allur
host
target
potenti
identifi
develop
broadspectrum
antivir
agent
particularli
attract
emerg
infect
sar
coronaviru
outbreak
case
broadspectrum
agent
could
allow
effect
treatment
without
lead
time
necessari
develop
virusspecif
therapi
broadspectrum
inhibitor
would
also
welcom
treatment
nich
indic
progress
multifoc
leukoencephalopathi
pml
caus
uncontrol
jc
viru
infect
central
nervou
system
immunecompromis
patient
case
medic
need
acut
patient
popul
larg
enough
provid
econom
incent
develop
virusspecif
drug
current
mani
health
care
provid
use
interferon
ribavirin
offlabel
treat
seriou
viral
infect
approv
therapi
drug
provid
benefit
case
efficaci
typic
quit
modest
numer
side
effect
mani
seriou
associ
use
drug
leyssen
et
al
borden
et
al
detail
advers
event
associ
interferon
ribavirin
use
see
http
http
manuscript
describ
novel
antivir
compound
tetrahydrocarbazol
uniqu
profil
initi
data
suggest
broadspectrum
antivir
activ
via
host
target
manuscript
describ
antivir
data
number
vitro
viral
replic
system
discuss
implic
preliminari
mechan
action
studi
n
fig
enantiom
synthes
glaxosmithklin
research
triangl
park
nc
bogg
et
al
molecular
weight
stock
solut
serial
dilut
prepar
dimethyl
sulfoxid
dmso
experi
equal
volum
serial
dilut
ad
growth
medium
final
solut
includ
untreat
control
contain
concentr
dmso
vv
detail
cell
cell
line
use
studi
growth
media
use
cultur
found
supplementari
materi
human
origin
except
vero
cell
line
cell
type
prepar
laboratori
describ
peripher
blood
mononuclear
cell
pbmc
prepar
buffi
coat
previous
describ
ferri
et
al
b
cell
cell
prepar
human
blood
obtain
inform
consent
neg
select
use
stemcel
technolog
rosettesep
techniqu
accord
manufactur
protocol
puriti
prepar
b
cell
cell
b
cell
activ
addit
gml
solubl
ligand
r
system
ngml
r
system
nm
phorbol
pma
sigma
pbmc
activ
phytohemagglutinin
previous
describ
ferri
et
al
case
cell
doubl
time
within
h
stimul
blcl
mix
popul
b
lymphoblastoid
cell
prepar
infect
pbmc
strain
ebv
describ
frisan
et
al
medium
stanley
et
al
dmem
mem
rpmi
growth
media
obtain
invitrogen
carlsbad
ca
eagl
mem
obtain
atcc
kgm
egm
mv
media
obtain
cambrex
east
rutherford
nj
unless
otherwis
specifi
medium
contain
vv
fetal
bovin
serum
either
gentamicin
gml
penicillin
iuml
plu
streptomycin
gml
cultur
grown
c
atmospher
contain
co
bone
marrow
toxic
assay
run
cambrex
bio
scienc
walkersvil
inc
east
rutherford
nj
use
method
describ
eav
measur
employ
mt
assay
cori
et
al
reduct
cell
inner
salt
mt
measur
celltit
aqueou
mt
reagent
powder
purchas
promega
phenazin
methosulf
purchas
sigma
suggest
protocol
promega
follow
h
incub
cell
reagent
c
co
absorb
read
nm
use
wallac
victor
multilabel
plate
reader
shown
net
proport
number
thu
mass
viabl
cell
verifi
cell
data
shown
experi
sensit
dynam
rang
increas
carri
kinet
measur
h
addit
reagent
use
tecan
spectrafluor
plu
plate
reader
plate
maintain
c
per
hour
calcul
linear
regress
linear
portion
curv
experi
cell
growth
viabil
estim
cellular
atp
measur
use
celltiterglo
luminesc
cell
viabil
assay
ctg
promega
accord
manufactur
protocol
luminesc
measur
use
wallac
victor
plate
reader
hff
cell
plate
well
plate
cellswel
sixteen
hour
plate
cell
infect
adenoviru
type
atcc
moi
h
viru
remov
cell
l
fresh
medium
contain
compound
concentr
rang
ad
well
incub
day
cell
cultur
fluid
remov
cell
rins
pb
twice
intracellular
adenoviru
dna
hff
quantifi
qpcr
describ
vero
cell
plate
well
plate
cellswel
cell
allow
adher
well
h
infect
strain
atcc
moi
h
supernat
remov
cell
dilut
compound
rang
ad
incub
day
cell
assay
growth
mt
dna
qpcr
describ
hybrid
captur
assay
dna
cell
seed
cellswel
well
platecontain
compound
concentr
rang
plate
incub
c
presenc
co
day
cell
lyse
naoh
igep
episom
dna
quantifi
use
nonradioact
hybrid
captur
techniqu
specif
captur
detect
probe
hybrid
plate
nunc
maxisorb
well
cat
coat
mixtur
captur
probe
reactibind
solut
pierc
least
h
wash
ssc
ssct
prior
block
lwell
naoh
igep
mgml
her
sperm
dna
h
hybrid
carri
mix
l
lyse
cell
l
denatur
detect
probe
guanidin
isothiocyan
prevent
evapor
l
miner
oil
ad
well
plate
heat
c
min
hybrid
continu
c
overnight
assay
plate
wash
time
ssct
antidigoxigenin
hrpconjug
antibodi
boehring
mannheim
tabl
inhibit
replic
hff
cell
replic
vero
cell
host
cell
viral
dna
qpcr
uninfect
host
cell
growth
mt
select
index
hff
b
vero
na
c
calcul
data
fig
sinc
valu
imax
close
k
b
sinc
valu
imax
close
k
c
na
sinc
vero
cell
inhibit
differ
dose
respons
function
select
index
calcul
incub
well
min
room
temperatur
wash
supersign
lba
substrat
pierc
cat
ad
chemiluminesc
measur
use
wallac
victor
plate
reader
cell
grown
plate
format
medium
remov
aspir
cell
wash
buffer
salin
lyse
addit
l
solut
contain
mm
trishcl
ph
mm
kcl
mm
mgcl
wv
wv
tween
proteinas
k
mgml
incub
c
h
proteinas
k
inactiv
heat
plate
c
min
dna
quantifi
l
aliquot
sampl
use
invitrogen
quantit
pcr
kit
cat
abi
ht
system
c
min
c
min
cycl
run
c
c
c
actin
min
primer
probe
use
synthes
mega
base
inc
evanston
il
list
supplementari
materi
final
concentr
qpcr
reaction
mixtur
nm
cell
grown
cm
flask
medium
aspir
cell
wash
chill
pb
cell
lyse
total
rna
extract
lysat
use
qiagen
rneasi
mini
kit
follow
manufactur
protocol
aliquot
total
rna
profil
agil
bioanalyz
assess
rna
qualiti
level
mrna
select
gene
see
supplementari
materi
measur
quadrupl
rtqpcr
briefli
total
rna
sampl
treat
dnafre
tm
deoxyribonucleas
ambion
usa
remov
genom
dna
effici
dnase
procedur
valid
standard
taqman
assay
use
gapdh
probe
primer
set
standard
pcr
reaction
dnafre
total
rna
sampl
quantifi
use
ribogreen
rna
quantit
reagent
molecular
probe
first
strand
cdna
synthesi
carri
use
high
capac
cdna
archiv
kit
appli
biosystem
foster
citi
ca
gene
specif
primer
design
use
primer
express
softwar
appli
biosystem
foster
citi
ca
confirm
blast
search
use
public
proprieti
sequenc
databas
experiment
valid
final
concentr
forward
revers
primer
assay
nm
final
concentr
fluorogen
probe
nm
see
supplementari
materi
primerprob
sequenc
quantit
pcr
carri
use
sequenc
detector
system
appli
biosystem
l
reaction
volum
univers
pcr
master
mix
appli
biosystem
univers
pcr
condit
recommend
vendor
appli
biosystem
use
express
level
gene
calcul
mean
cycl
threshold
valu
ct
normal
level
gadph
mrna
express
chang
express
level
due
treatment
first
calcul
dct
ct
control
ct
treat
statist
signific
dct
valu
calcul
use
twosid
ttest
fold
increas
signific
chang
p
calcul
f
dct
apoptosi
estim
measur
cytoplasm
histoneassoci
dna
fragment
use
cell
death
detect
elisa
kit
boehring
mannheim
accord
manufactur
instruct
sensit
dynam
rang
assay
increas
carri
kinet
measur
absorb
nm
tecan
spectrofluor
plu
plateread
c
per
hour
calcul
linear
regress
linear
portion
curv
fasactiv
antibodi
upstat
biotechnolog
use
posit
control
cell
grown
plate
ml
medium
per
well
indic
time
ml
steadyglo
luciferas
reagent
promega
ad
well
luminesc
measur
min
addit
use
wallac
victor
plate
reader
inhibit
doserespons
curv
analyz
fit
modifi
form
hill
equat
hill
ctrl
percent
control
respons
concentr
x
inhibitor
max
asymptot
maximum
level
inhibit
observ
x
increas
k
median
effect
concentr
inhibitor
concentr
ctrl
max
n
hill
coeffici
maximum
level
inhibit
eq
reduc
eq
familiar
form
hill
equat
eq
k
inhibitor
concentr
give
ctrl
case
k
equal
ec
cc
valu
k
max
standard
error
calcul
fit
inhibit
data
eq
use
nonlinear
regress
program
base
modifi
marquardtlevenberg
algorithm
mager
valu
report
mean
standard
error
se
least
two
independ
measur
fit
data
eq
gave
valu
max
significantli
less
inhibit
paramet
report
k
median
effect
concentr
max
data
use
term
ec
cc
appropri
illustr
exampl
doserespons
curv
max
equal
less
see
tabl
valu
max
close
clear
asymptot
level
inhibit
highest
concentr
test
inhibit
paramet
report
ec
cc
tabl
effect
growth
cell
line
immort
episom
ebv
integr
cell
line
growth
host
primari
cell
host
primari
cell
growth
select
index
ebv
activ
b
cell
blcl
ebv
activ
b
cell
activ
cell
calcul
data
fig
sinc
valu
imax
close
k
adenoviru
fig
inhibit
replic
primari
human
fibroblast
hff
fig
tabl
median
effect
concentr
k
nm
maximum
inhibit
max
case
max
valu
almost
k
ec
valu
equival
growth
uninfect
hff
measur
mt
inhibit
concentr
one
micromolar
cc
nm
experi
averag
nm
number
differ
experi
tabl
select
index
inhibit
adenoviru
replic
cytotox
hff
thu
greater
tabl
observ
antivir
activ
stereospecif
contrast
potent
inhibit
enantiom
affect
adenoviru
replic
concentr
one
micromolar
ec
data
shown
also
inhibit
replic
polyoma
viru
vero
cell
fig
tabl
median
effect
concentr
k
nm
maximum
inhibit
max
case
interpret
data
complic
fact
growth
host
vero
cell
also
inhibit
similar
median
effect
concentr
k
nm
maximum
inhibit
cell
growth
max
howev
significantli
lower
viral
replic
differ
max
val
ue
antivir
growth
effect
suggest
antivir
effect
distinct
effect
cell
growth
address
issu
calcul
ratio
dna
mt
activ
infect
vero
cell
ratio
proport
viral
dna
per
cell
seen
fig
fall
increas
concentr
median
effect
concentr
k
reduct
ratio
nm
maximum
inhibit
max
result
suggest
reduc
replic
differ
form
doserespons
curv
inhibit
viral
yield
inhibit
growth
host
vero
cell
unabl
calcul
select
index
system
avail
studi
infect
primari
cell
limit
abil
calcul
true
select
index
show
inhibit
growth
number
cell
line
immort
either
viral
infect
case
vero
cell
nonvir
event
effect
infect
vero
cell
infect
pbmc
also
studi
concentr
rang
nm
contrast
result
compar
weak
inhibit
seen
inhibit
micromolar
rang
similarli
inhibit
lytic
replic
ebv
induc
sodium
butyr
pma
cell
signific
inhibit
occur
data
shown
experiment
design
cell
type
describ
legend
fig
valu
k
imax
calcul
fit
eq
data
shown
fig
lymphoblastoid
b
cell
line
immort
episom
epsteinbarr
viru
cell
line
transform
integr
human
tcell
leukemia
viru
potent
inhibitor
growth
cell
line
fig
tabl
median
effect
concentr
nm
respect
maximum
inhibit
achiev
greater
control
cell
line
level
reach
nm
addit
curv
shown
viral
yield
measur
cell
quantit
pcr
found
decreas
parallel
inhibit
cell
growth
data
shown
also
found
inhibit
newli
prepar
mix
blcl
line
tabl
dose
respons
ident
enantiom
rel
inact
ec
valu
nm
nm
cell
data
shown
effect
primari
cell
type
infect
cell
line
origin
deriv
also
measur
fig
tabl
inhibit
activ
b
cell
seen
nanomolar
rang
cc
valu
case
greater
select
index
calcul
inhibit
ebvimmort
line
versu
activ
b
cell
thu
inhibit
line
versu
activ
cell
tabl
cell
line
creat
immort
human
keratinocyt
episom
potent
inhibitor
hpv
dna
level
grow
cell
median
effect
concentr
determin
use
hybrid
captur
assay
nm
maximum
inhibit
max
hpv
level
greater
control
max
valu
reach
concentr
nm
fig
tabl
case
vero
cell
howev
effect
growth
cell
k
valu
compound
effect
viral
dna
growth
similar
differ
max
valu
tabl
case
growth
inhibit
max
approach
rather
asymptot
control
ratio
hpv
dna
mt
activ
calcul
result
doserespons
curv
significantli
differ
inhibit
total
hpv
dna
fig
tabl
sinc
ratio
proport
viral
dna
copi
number
per
cell
suggest
reduc
hpv
viral
copi
number
independ
effect
cell
function
reduct
copi
number
confirm
measur
hpv
cellular
actin
dna
quantit
pcr
tabl
similar
valu
k
observ
max
valu
slightli
lower
calcul
gene
number
data
show
nm
copi
number
express
hpv
genom
per
actin
gene
reduc
enantiom
rel
inact
ec
valu
nm
reduct
hpv
dna
nm
inhibit
growth
cell
data
shown
littl
impact
growth
uninfect
human
keratinocyt
cc
primari
cell
approxim
fig
tabl
give
select
index
reduct
hpv
dna
compar
inhibit
hkc
growth
result
cell
extend
measur
hpv
dna
hpvbear
cell
use
quantit
pcr
dna
assay
keratinocyt
line
immort
second
high
risk
viru
anoth
line
use
k
valu
reduct
hpv
dna
gsk
cell
line
similar
compar
valu
measur
cell
effect
growth
three
cell
line
also
similar
tabl
although
necessari
viral
replic
integr
part
adenoviru
ebv
hpv
genom
occur
chanc
event
recombin
viral
replic
gener
immort
cell
line
examin
effect
growth
sever
cell
line
result
fig
tabl
line
test
suscept
median
effect
concentr
k
rang
nm
averag
nm
valu
k
inhibit
line
integr
ebv
namalwa
significantli
differ
inhibit
correspond
product
episom
infect
four
keratinocyt
line
integr
hpv
howev
less
suscept
episom
infect
line
contrast
observ
maximum
inhibit
viral
dna
product
episom
infect
max
valu
integr
line
asymptot
significantli
less
max
valu
vari
namalwa
experiment
design
cell
type
describ
legend
fig
valu
k
imax
calcul
fit
eq
data
cell
line
except
siha
shown
fig
form
doserespons
curv
inhibit
cell
line
integr
viru
similar
observ
growth
hpvinfect
cell
line
fig
vero
cell
line
fig
vero
cell
african
green
monkey
kidney
cell
immort
unknown
event
probabl
viral
infect
led
us
studi
effect
growth
five
cell
line
human
origin
immort
nonvir
transform
event
tabl
result
show
characterist
form
doserespons
curv
median
effect
concentr
rang
nm
maximum
inhibit
asymptot
valu
less
wherev
possibl
studi
compar
effect
viral
infect
transfect
cell
line
effect
primari
cell
type
cell
line
origin
deriv
fig
tabl
case
cc
inhibit
primari
cell
growth
greater
tabl
show
addit
data
hff
cell
measur
effect
growth
type
primari
cell
includ
pbmc
rest
b
cell
fibroblast
huvec
endotheli
cell
two
type
bone
marrow
progenitor
none
primari
cell
type
test
significantli
inhibit
concentr
inhibit
seen
rang
unlik
viral
assay
clearli
potent
enantiom
primari
cell
similar
cc
valu
observ
enantiom
data
shown
suggest
inhibit
primari
cell
like
separ
mechan
respons
antivir
data
present
erythroid
granulocytemacrophag
toxic
assay
run
cambrex
bio
scienc
walkersvil
inc
use
method
describ
eav
cell
type
grown
use
media
indic
supplementari
materi
cell
plate
plate
medium
contain
serial
dilut
concentr
rang
nm
measur
cell
growth
determin
ctg
hff
b
cell
mt
hff
pbmc
huvec
h
incub
c
valu
calcul
fit
data
eq
result
present
show
two
distinct
type
growth
inhibit
curv
immort
cell
inhibit
observ
line
fig
less
maximum
inhibit
observ
mani
cell
line
includ
fig
tabl
measur
inhibit
cours
h
determin
reason
two
distinct
pattern
time
period
cell
line
doubl
time
see
inhibit
experi
cell
death
must
occur
maximum
inhibit
significantli
inhibit
like
due
cytostasi
fig
show
measur
growth
cell
period
day
addit
rang
concentr
growth
threecel
line
exponenti
throughout
time
doubl
time
h
respect
presenc
concentrationdepend
decreas
rate
growth
seen
reach
zero
nm
remain
zero
higher
concentr
result
indic
induct
cytostasi
consist
asymptot
doserespons
curv
cell
similar
studi
vero
cell
data
shown
also
indic
cytostasi
consist
dose
respons
contrast
growth
rate
cell
becom
neg
higher
concentr
indic
cell
death
consist
observ
dose
respons
max
approach
growth
curv
show
inhibit
immedi
regardless
whether
final
outcom
cytostasi
cell
death
reduct
growth
rate
occur
approxim
h
addit
compound
fig
mechan
cell
death
investig
measur
apoptosi
cell
line
expos
drug
fig
apoptosi
cell
line
apoptosi
occur
cell
line
asymptot
dose
respons
result
expect
inhibit
result
cytostasi
line
two
control
use
studi
inact
enantiom
induc
apoptosi
cell
line
studi
cell
line
suscept
posit
control
fasactiv
antibodi
biolog
profil
includ
activ
varieti
virus
immort
cell
line
suggest
target
cellular
protein
observ
delay
onset
inhibit
suggest
mechan
action
requir
induct
cellular
gene
thu
studi
effect
express
set
human
gene
select
independ
studi
investig
metabol
signal
pathway
pathway
set
see
supplementari
materi
detail
experi
carri
cell
sinc
cytostat
inhibit
cell
permit
reliabl
prepar
intracellular
mrna
gene
whose
express
upregul
identifi
two
criteria
first
concentr
near
ec
nm
statist
signific
increas
express
seen
compar
valu
h
treatment
untreat
control
minimum
signific
increas
detect
base
observ
standard
error
tabl
second
increas
show
reason
dose
respons
h
treatment
nm
statist
signific
increas
least
seen
compar
untreat
control
result
tabl
nm
produc
signific
increas
express
gene
hpvimmort
cell
gene
primari
human
keratinocyt
one
gene
induc
cell
type
gene
induc
cell
seven
oasl
trail
known
interferonstimul
gene
isg
use
four
publish
list
isg
brown
et
al
der
et
al
radaeva
et
al
determin
gene
pathway
set
isg
thu
gene
set
select
random
one
would
expect
isg
set
gene
induc
cell
isg
overrepres
calcul
chisquar
show
probabl
overrepresent
due
chanc
two
chemokin
occur
gene
induc
cell
number
also
significantli
greater
expect
chanc
isg
chemokin
found
set
gene
upregul
hkc
rna
sampl
test
express
five
addit
isg
includ
pathway
set
tabl
three
strongli
induc
cell
hkc
result
two
signific
summari
induc
limit
set
gene
cell
major
compon
set
interferonstimul
gene
result
also
show
isg
upregul
notabl
three
interferon
alpha
beta
gamma
pkr
induc
data
shown
verifi
result
restrict
cell
check
induct
anoth
suscept
cell
line
use
strain
stabli
transfect
luciferas
gene
control
promot
result
fig
strong
induct
luciferas
seen
nm
period
result
compar
induct
posit
control
unitsml
result
present
show
broad
spectrum
activ
inhibit
viral
replic
growth
immort
cell
rel
narrow
rang
nm
effect
howev
quit
select
compound
impact
growth
primari
cell
studi
concentr
number
antivir
assay
present
straightforward
system
interpret
inhibit
adenoviru
system
viru
complet
full
life
cycl
monolay
cell
cultur
primari
cell
see
classic
antivir
doserespons
curv
full
inhibit
max
occur
nm
impact
viral
replic
directli
compar
compound
impact
growth
uninfect
hff
minim
select
index
clearli
indic
inhibit
viral
replic
antivir
system
present
complic
interpret
sinc
use
immort
cell
result
detail
clearli
indic
immort
cell
line
evalu
suscept
regardless
whether
viru
present
tabl
time
cours
apoptosi
experi
demonstr
effect
typic
cytostasi
case
apoptosi
fig
experi
first
exampl
use
immort
cell
case
standard
assay
measur
product
replic
vero
cell
sinc
vero
growth
inhibit
even
absenc
viru
challeng
separ
antivir
growth
inhibit
effect
note
section
use
ratio
viral
dna
mt
activ
indic
level
viral
dna
per
cell
analysi
demonstr
signific
reduct
viral
dna
fig
suggest
antivir
effect
prove
antivir
effect
directli
due
action
rather
secondari
cytostasi
host
cell
case
cell
line
immort
episom
retrovir
integr
viru
much
clearer
analysi
possibl
rna
sampl
experi
tabl
analyz
quadrupl
rtqpcr
mrna
level
gene
list
chang
express
level
due
treatment
calcul
describ
section
rel
gadph
mrna
ct
b
fold
chang
significantli
differ
three
hpvinfect
cell
line
viral
dna
level
inhibit
k
valu
nm
maximum
level
inhibit
approach
cell
growth
also
inhibit
similar
k
valu
show
cell
inhibit
cytostat
result
maximum
inhibit
significantli
less
first
analysi
look
ratio
hpv
dna
mt
activ
reduc
indic
drop
viral
copi
number
per
cell
confirm
qpcr
suggest
select
antivir
effect
second
approach
studi
select
measur
effect
primari
human
keratinocyt
uninfect
cell
close
relat
line
found
differ
k
valu
fig
tabl
although
comparison
perfect
sinc
cell
differ
genet
lineag
strongli
suggest
select
effect
data
cell
line
immort
either
episom
integr
hpv
allow
us
form
initi
hypothes
action
line
two
thing
common
first
growth
depend
viru
second
growth
inhibit
similar
median
effect
concentr
k
k
valu
growth
also
similar
median
effect
concentr
inhibit
viral
yield
consid
mechan
envis
three
possibl
explan
role
observ
activ
first
could
inhibit
viral
replic
inhibit
could
lead
cytostasi
sinc
growth
cell
line
depend
viru
case
observ
inhibit
depend
copi
number
cell
line
approxim
episom
copi
hpv
stanley
et
al
line
episom
copi
lee
et
al
integr
line
even
fewer
copi
line
similar
growth
rate
data
shown
k
valu
inhibit
tabl
furthermor
observ
similar
effect
growth
episom
line
copi
number
decreas
integr
line
copi
number
fix
tabl
second
possibl
explan
reduct
viral
copi
number
simpl
consequ
induct
cytostasi
also
unlik
sinc
cytostasi
induc
uninfect
keratinocyt
clearli
requir
presenc
viru
tabl
consequ
third
explan
seem
like
reduct
viral
copi
number
cell
growth
rate
parallel
consequ
effect
singl
target
result
ebv
immort
cell
line
lead
conclus
even
though
appear
differ
first
glanc
fig
sinc
inhibit
manifest
apoptosi
rather
cytostasi
fig
compar
potent
inhibit
viralimmort
cell
line
lack
effect
relat
primari
cell
give
select
index
approxim
imperfect
comparison
sinc
genet
lineag
primari
immort
cell
ident
suggest
select
effect
clearli
show
caus
apoptosi
primari
cell
even
activ
also
note
number
cell
line
passag
sinc
viral
immort
event
influenc
outcom
assay
freshli
immort
blcl
behav
fashion
much
older
cell
line
suggest
viral
immort
key
cell
line
suscept
event
may
occur
subsequ
round
replic
preliminari
mechan
action
studi
time
cours
growth
presenc
fig
show
delay
inhibit
first
h
suggest
mechan
could
involv
induct
gene
set
gene
host
cell
studi
compar
gene
express
hpv
system
primari
keratinocyt
reveal
subset
interferonstimul
gene
upregul
cell
primari
keratinocyt
result
confin
hpv
system
confirm
second
cell
line
immort
adenoviru
fig
also
notabl
neg
result
interferon
upregul
obvious
still
signific
amount
work
need
fulli
understand
mechan
mechan
initi
experi
point
use
start
point
identifi
target
possibl
multipl
activ
describ
result
action
similar
potenc
multipl
target
instanc
current
data
rule
scenario
antivir
effect
replic
primari
cell
due
inhibit
viral
target
effect
observ
immort
transform
cell
line
due
separ
mechan
cellular
target
case
mechan
still
interest
compound
potent
inhibit
adenoviru
clear
select
immort
cell
primari
cell
data
present
also
consist
anoth
assumpt
effect
manifest
rel
narrow
concentr
rang
could
result
action
compound
singl
cellular
target
case
cell
line
viral
replic
suscept
must
common
featur
share
primari
cell
viral
replic
suscept
suscept
cell
line
whether
immort
viral
infect
integr
viral
gene
nonvir
mean
abnorm
cellular
dna
replic
loss
normal
cell
cycl
control
definit
primari
cell
type
featur
furthermor
show
two
virus
activ
turn
cellular
dna
replic
product
replic
suscept
hpv
share
properti
knipe
howley
inhibit
fig
unabl
studi
product
replic
hpv
due
lack
suitabl
experiment
system
virus
studi
suscept
either
activ
promot
cellular
dna
replic
case
hiv
activ
block
case
lytic
replic
herpesvirus
ebv
kudoh
et
al
hsv
song
et
al
thu
suscept
correl
loss
normal
cell
cycl
control
abrog
cell
cycl
control
either
viral
immort
event
trigger
varieti
host
cell
defens
lead
cytostasi
apoptosi
order
continu
viral
replic
immort
defens
must
inactiv
preliminari
studi
suggest
mechan
action
may
allow
cellular
defens
reactiv
result
reactiv
synthesi
subset
interferonstimul
gene
mechan
could
time
produc
direct
antivir
effect
cellcycl
arrest
apoptosi
observ
review
randal
goodbourn
propos
mechan
would
also
explain
lack
observ
activ
primari
cell
type
studi
activ
depend
upon
prior
viral
immort
event
compound
would
effect
upon
primari
cell
conclus
novel
tetrahydrocarbazol
inhibit
multipl
virus
appear
uniqu
mechan
action
function
via
cellular
target
target
import
replic
mani
virus
growth
immort
cell
intrigu
biolog
profil
warrant
studi
